01 / Vendor Profile
BIOCRYST PHARMACEUTICALS, INC. Federal Contracts and Awards
UEI MGXADJ6SCLJ5 · CAGE 4GBX7
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $12.82M in net contract obligations to BIOCRYST PHARMACEUTICALS, INC. across 44 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
BIOCRYST PHARMACEUTICALS, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$28.79M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $6.93M | 2 | 1 | — |
| FY 2020 | $16.08M | 8 | 2 | +132.0% |
| FY 2021 | $8.32M | 4 | 2 | −48.3% |
| FY 2022 | $7.83M | 5 | 3 | −5.9% |
| FY 2023 | -$198.6K | 3 | 1 | −102.5% |
| FY 2024 | $2.66M | 9 | 3 | +1,438.9% |
| FY 2025 | -$28.79M | 13 | 2 | −1,182.9% |
04 / Federal Customers
Which federal agencies buy from BIOCRYST PHARMACEUTICALS, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $7.34M | 10 | 57.2% | |
| 7505 | $3.08M | 14 | 24.0% | |
| 3600 | $2.41M | 20 | 18.8% |
05 / Contracting Offices
Which contracting offices buy from BIOCRYST PHARMACEUTICALS, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75A503 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $13.88M | 2 | 108.2% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $7.34M | 10 | 57.2% | |
| 36C260 | VETERANS AFFAIRS, DEPARTMENT OF | $2.41M | 18 | 18.8% | |
| 36C261 | VETERANS AFFAIRS, DEPARTMENT OF | $0 | 2 | 0.0% | |
| 75A501 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | -$10.80M | 12 | -84.2% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $44.02M | 27 | 2 | 343.3% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $2.61M | 6 | 1 | 20.4% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | -$3.94M | 9 | 2 | -30.7% |
| 541710 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES | -$29.87M | 2 | 1 | -232.9% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6505 | DRUGS AND BIOLOGICALS | $44.02M | 27 | 2 | 343.3% |
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $4.72M | 4 | 1 | 36.8% |
| AJ12 | GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $2.61M | 6 | 1 | 20.4% |
| AN13 | R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) | -$38.53M | 7 | 1 | -300.5% |
08 / Competition Pattern
How was BIOCRYST PHARMACEUTICALS, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for BIOCRYST PHARMACEUTICALS, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 36C26025F0024 | Aug 20, 2025 | $29.4K | VETERANS AFFAIRS, DEPARTMENT OF 260-NETWORK CONTRACT OFFICE 20 (36C260) | 325412 | 6505 |
10 / Interpreting the Profile
How should you evaluate BIOCRYST PHARMACEUTICALS, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.